Patient website
A dedicated source of information designed especially for patients.
Not a healthcare professional? Visit our Public site
Not a healthcare professional? Visit our Public site
has been added to your basket
59
Resources and downloadable booklets created to help you support your patients who have been prescribed Zejula (niraparib).
GSK and HealthNet offer a 3-part service to help you monitor your patients throughout their treatment.
MoA, mechanism of action; QoL, quality of life.
References
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221 4411 or UKSafety@gsk.com
© 2022 GSK Group of Companies or its licensor. Trademarks are the property of their respective owners.
June 2023 | PM-GB-NRP-WCNT-220010 (V2.0)